Expression of Ki-67, topoisomerase IIalpha and c-MYC in astrocytic tumors: correlation with the histopathological grade and proliferative status.
about
The accuracy of survival time prediction for patients with glioma is improved by measuring mitotic spindle checkpoint gene expressionThree-dimensional nuclear telomere architecture is associated with differential time to progression and overall survival in glioblastoma patientsEvaluation of the proliferation markers Ki-67/MIB-1, mitosin, survivin, pHH3, and DNA topoisomerase IIα in human anaplastic astrocytomas--an immunohistochemical studyMechanism of p27 upregulation induced by downregulation of cathepsin B and uPAR in gliomaIntracranial metastasis of spinal intramedullary anaplastic astrocytomaMiR-106a is an independent prognostic marker in patients with glioblastoma.Neural stem cells, inflammation and NF-kappaB: basic principle of maintenance and repair or origin of brain tumours?cMYC expression in infiltrating gliomas: associations with IDH1 mutations, clinicopathologic features and outcome.Prognostic markers of astrocytoma: how to predict the unpredictable?Higher topoisomerase 2 alpha gene transcript levels predict better prognosis in GBM patients receiving temozolomide chemotherapy: identification of temozolomide as a TOP2A inhibitor.Intracranial dissemination from spinal cord anaplastic astrocytoma.Prognostic relevance of c-Myc and BMI1 expression in patients with glioblastoma.Hyperdiploid tumor cells increase phenotypic heterogeneity within Glioblastoma tumors.Image analysis is an excellent tool for quantifying Ki-67 to predict the prognosis of gastrointestinal stromal tumor patients.Clustering methods applied in the detection of Ki67 hot-spots in whole tumor slide images: an efficient way to characterize heterogeneous tissue-based biomarkers.Intracranial spreading of a spinal anaplastic astrocytoma.Immunoexpression of tumor suppressor genes p53, p21 WAF1/CIP1 and p27 KIP1 in humam astrocystic tumors.
P2860
Q28743982-1DA7FC24-8419-4888-8B78-EA6252B2BC19Q33622602-13A9A56D-B29B-4AFC-88B0-49321C389A3CQ35081279-B9DFB0A0-9C59-4FB4-B52D-F163AE59B985Q35244054-20C45F80-9145-4275-B3FB-0D89A0AE35B7Q35749474-E271E3CD-E4A4-444A-AEC5-0830EE2034B6Q36865988-4F5C8666-7F7E-43C9-B0CD-01C8C49AED3BQ37053186-49A39476-8CAF-4034-9EDD-AA31841E8480Q37435393-97BBA600-484D-4EE5-8DDE-C09A9714F721Q38089921-9CC06BF3-BB8F-43AC-891B-4A22CE815DE5Q39439785-B224020F-0C3C-477B-8992-A7561F70A1DBQ41971383-D1B65EA7-32BB-462E-8008-A9AEECCBEE2EQ43995999-B80D0B8E-3940-4528-A29A-350A9249B99CQ46581912-088CD93D-78AB-4363-9A13-6816E7E1D870Q48520915-E4CB73A9-1E34-419F-9937-D986B41428F4Q48566685-F58898E8-8938-47B6-90DA-966400FC8242Q48867537-2EC05B3F-51AE-4E83-9FCE-ACFA000EA301Q55466958-8C77726F-FE1B-4D82-A012-164A08AC3E3A
P2860
Expression of Ki-67, topoisomerase IIalpha and c-MYC in astrocytic tumors: correlation with the histopathological grade and proliferative status.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Expression of Ki-67, topoisome ...... rade and proliferative status.
@en
Expression of Ki-67, topoisome ...... rade and proliferative status.
@nl
type
label
Expression of Ki-67, topoisome ...... rade and proliferative status.
@en
Expression of Ki-67, topoisome ...... rade and proliferative status.
@nl
prefLabel
Expression of Ki-67, topoisome ...... rade and proliferative status.
@en
Expression of Ki-67, topoisome ...... rade and proliferative status.
@nl
P2093
P2860
P1433
P1476
Expression of Ki-67, topoisome ...... rade and proliferative status.
@en
P2093
Bronner P A Gonçalves
Manoel O de Moraes-Filho
Mário H G Faria
Régia M do S V do Patrocínio
Silvia H B Rabenhorst
P2860
P304
P356
10.1111/J.1440-1789.2006.00724.X
P577
2006-12-01T00:00:00Z